gamma-glu-asp has been researched along with 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid in 1 studies
Studies (gamma-glu-asp) | Trials (gamma-glu-asp) | Recent Studies (post-2010) (gamma-glu-asp) | Studies (3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid) | Trials (3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid) | Recent Studies (post-2010) (3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid) |
---|---|---|---|---|---|
21 | 0 | 6 | 117 | 2 | 4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Destrade, C; Eichenlaub, D; Mélan, C; Messier, C; Ungerer, A | 1 |
1 other study(ies) available for gamma-glu-asp and 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid
Article | Year |
---|---|
Blockade of spontaneous posttraining performance improvement in mice by NMDA antagonists.
Topics: Animals; Conditioning, Operant; Dipeptides; Excitatory Amino Acid Antagonists; Generalization, Psychological; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Piperazines; Receptors, N-Methyl-D-Aspartate; Retention, Psychology; Species Specificity | 1997 |